Principal Research Scientist - Pharmaceutical Pricing Practices and Policies Research

JOB SUMMARY

NORC at the University of Chicago seeks an experienced Principal Research Scientist to direct program and policy projects, with an emphasis on those related to pharmaceutical drug pricing practices and costs.

This position will have a hybrid work schedule of one to two days a week in either our Chicago, IL or Washington, DC office.

NORC's expertise and ongoing work in health care delivery and financing - including access to insurance, payment and delivery-system reform, benefit design, and quality measurement - advance stakeholders' understanding of policies and programs, facilitate implementation, and contribute to important improvements in cost and quality.

NORC's expert staff has extensive knowledge of all aspects of health care delivery, from private marketplaces and employer-sponsored insurance to Medicare and Medicaid; from large health care systems to small clinics; and from the needs of children to those of older adults, people with disabilities, and ethnic and racial minorities. Our expert team includes social scientists that acquire, collect, and analyze data from health care organizations and patients;

evaluators; health services researchers; health-policy analysts; and professionals with first‑hand experience running and supporting health care programs.

• Play a lead role in growing NORC's portfolio in the area of pharmaceuticals and prescription‑drug pricing and policy
• Provide consultative pricing analysis, evaluation expertise, and operational and technical support for federal clients on the following topics and their impact on prescription drug pricing
  • Inflation Reduction Act (IRA) provisions
  • Most Favored Nation (MFN) pricing
  • Utilization management
  • New therapeutic alternative market entry
  • Macro‑economic trends
  • Loss of exclusivity
  • 340b
• Design and conduct quantitative health economics modeling studies, evaluations, and analyses such as cost effectiveness, cost benefit, budget impact, network meta‑analysis, and others to demonstrate the impact of policy changes on prescription drug pricing.
• Provide methods and estimations for price (or proxies), rebates, and margins calculations across pharmaceutical supply chains for Medicare Part B & D, Medicaid, Commercial, 340B and Big
  4.
• Independently draft and manage contract proposals and grant applications, communicating effectively with clients, consultants, and members of the policy and research community.
• Participate in and contribute to internal discussions and strategic thinking concerning future research opportunities and the implications of ongoing policy‑making for NORC.
• Manage contracts and work closely with clients to ensure that contractual requirements (deliverables and timelines) and client expectations are met using the highest standards of quality and collegiality.
• Monitor and oversee the financial and administrative aspects of ongoing projects.
• Manage multiple project teams of senior, mid‑level, and junior staff, and bring in experts as needed, to meet client expectations and contractual requirements.
• Supervise and mentor junior staff.

• Master or Doctoral degree in economics or related fields (training in medical or pharmaceutical disciplines and work with pharmaceuticals for health economics, pricing, and market access will be considered). PhD or Pharm
  
  D preferred.
• At least 12 years' experience in positions of increasing responsibility in pharmaceutical pricing, market access, or related field (or equivalent education), including at least 5 years of project direction.
• Expert knowledge of IRA and MFN provisions, drug benefit redesign and their impact on prescription drug pricing.
• Knowledge/experience of estimating net of discounts and rebate Medicare Part D drug prices, Medicare Part B prices, Medicaid best prices from WAC and AMP, Pharmacy Benefits Manager (PBM) margins, net of discounts and rebate commercial prices, 340B prices, and volume of duplicates in Medicare and Medicaid.
• Knowledge/experience of utilization management, formulary placements, new therapeutic alternative market entry, loss of exclusivity, and their impact on drug pricing.
• Experience analyzing…